Guopan Li

Dr. Guopan Li

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2020 in Avian Pathology
Verified
Journal Article
Closed access
GLGuopan Li
Guopan Li
HKHongyan Kuang
Hongyan Kuang
HGHuaxiong Guo
Huaxiong Guo
LCLianshen Cai
Lianshen Cai
DCDianfeng Chu
Dianfeng Chu
JRJun Rong
Jun Rong
Since 2017, novel variant strains of infectious bursal disease virus (nvIBDV) have been detected in China, while the current vaccines against very virulent IBDV (vvIBDV) on the markets have limited protection against this subtype virus. In this context, a strain of the virus has been isolated, and sequencing alignment and animal regression experiments showed that the strain of the virus is IBDV, belonging to the nvIBDV subtype (and named IBDV FJ-1812). Furthermore, the E. coli expression system was used to successfully express soluble nvIBDV rVP2, which is specifically recognized by an anti-IBDV standard serum and anti-nvIBDV positive serum, and could be assembled into 14−17 nm virus-like particles. Based on the purified nvIBDV rVP2, we developed an IBDV FJ-1812 VP2 VLP vaccine at a laboratory scale to evaluate this vaccine protection; in addition, we also prepared an IBDV JZ 3/02 VP2 subunit vaccine targeting vvIBDV and evaluated its cross-protection against nvIBDV. Animal experiments results showed that the nvIBDV rVP2 vaccine could induce high titers of specific antibodies, completely protect the bursa of Fabricius from viral infection, and provide 100% immune protection to SPF and Rose 308 Broiler chickens; furthermore, the IBDV JZ 3/02 VP2 subunit vaccine targeting vvIBDV could provide 60% protection for SPF chickens and 80% protection for Rose 308 Broiler chickens. This report provides important technical supports for the prevention and control of nvIBDV in the future.

9 September 2026 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
GLGuopan Li
Guopan Li
SGSirong Gao
Sirong Gao
XAXiaoyang Ai
Xiaoyang Ai
JRJun Rong
Jun Rong
DCDisi Chen
Disi Chen
WGWeiwei Guo
Weiwei Guo
Fowl adenovirus serotype 11 (FAdV-11) is an emerging pathogen associated with inclusion body hepatitis (IBH) and high mortality in commercial broilers. In this study, we evaluated the protective efficacy of maternal antibody transfer against FAdV-11 in neonatal chicks. A hypervirulent FAdV-11 strain (FAdV-11/HB2022/1), isolated from an IBH outbreak in Hubei Province, China, caused 90% mortality in 1-day-old specific-pathogen-free (SPF) chickens; 7-day-old chicks exhibited no mortality but developed mild hepatic lesions and sustained viral replication. A soluble, trimeric Fiber subunit vaccine (Fiber282–569) was developed through rational truncation of the transmembrane domain, retaining both the shaft and head domains, with its homotrimeric conformation confirmed by size-exclusion chromatography coupled with multi-angle light scattering (SEC-MALS). Immunization of breeder hens with Fiber282–569 elicited high titers of FAdV-11-specific IgY and neutralizing antibodies that were efficiently transferred to progeny via the egg yolk. Upon lethal challenge with FAdV-11/HB2022/1, 1-day-old progeny chicks from vaccinated breeders exhibited 100% survival with no clinical signs, no gross pathological lesions, and undetectable viral loads in liver tissues, demonstrating complete protection. In contrast, all chicks from unvaccinated breeders succumbed within 5 days post-infection. These results demonstrate that maternal antibody transfer of the fiber-based subunit vaccine confers complete protection against lethal FAdV-11 infection in neonatal chicks, providing a safe and effective candidate strategy for controlling FAdV-11 in the poultry industry.